Effectiveness of Silodosin versus Tadalafil as Medical Expulsive Therapy for Lower Ureteric Calculi: A Randomized Controlled Trial
Abstract
Background: Medical expulsive therapy (MET) helps patients with lower ureteric calculi (LUC) pass their stones more easily. Although tadalafil and silodosin are promising MET agents, it is yet unknown how effective they are in comparison. The treatment efficacy of these medicines in LUC patients was compared in the current investigation. Methods: 90 patients were divided into two groups at random and given tadalafil (Group B) and silodosin (Group A) as prospective treatments. Every patient's age, sex, stone type, size, ejection rate, and pain episodes were noted and examined. Results: Groups A and B had mean ages of 39.1 (± 8.0) and 37.4 (± 8.2) years, respectively. With mean BMI values (kg/m2) of 27.1 (± 1.7) and 27.5 (± 1.6) for Groups A and B, respectively, the groups' sex distribution and comorbidities were comparable. Additionally, the mean stone type (radiopaque: 75.6% vs. 80.0%) and size (7.6 mm vs. 7.8 mm) were comparable. Silodosin treatment, however, resulted in a lower use of analgesics (198.8 mg vs. 247.8 mg, p < 0.001), fewer pain episodes (1.1 vs. 2.5, p < 0.001), and a greater expulsion rate (80.0% vs. 60.0%) and shorter expulsion duration (14.4 vs. 17.7 days, p < 0.001). With the exception of frequent irregular ejaculation with silodosin (17.8% vs. 4.4%), the side effects were comparable. Conclusion: In conclusion, even though silodosin is linked to an increased risk of irregular ejaculation, it is superior to tadalafil in encouraging stone removal while…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 90 participants or records.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.